Group offers "pharma leadership on demand”
A UK company has been launched with the aim of providing high level management expertise to pharmaceutical companies on an “on-demand” basis.
A UK company has been launched with the aim of providing high level management expertise to pharmaceutical companies on an “on-demand” basis.
Johnson & Johnson has tapped Chinese WuXi PharmaTech for additional R&D services, following the trend towards high-level, strategic collaborations between drugmakers and contract research organisations.
Cancer drugs could enter clinical trials and ultimately reach cancer patients faster thanks to legal contract templates created by the CEO Roundtable on Cancer.
Covidien hopes that a $100m (€74m) expansion of facilities at its production hub in St Louis, Missouri, US will boost efficiency and cut the time it takes to bring products to market.
ONI BioPharma has produced an antibiotic using its DPOLT technology, a solid phase synthesis platform for manufacturing bioactive peptides.
Data analysis may be the next aspect of the drug industry to be outsourced if the new virtual drug development network created by GSK and UK software firm InforSense is any indication.
in-PharmaTechnologist.com presents its latest round up personnel changes in the pharmaceutical sector.
The European Parliament has voted in favour of incorporating the United Nations’ (UN) Globally Harmonised System (GHS) for chemical packaging into EU law.